Daewoong Pharmaceutical Co., Ltd (KRX: 069620)
South Korea
· Delayed Price · Currency is KRW 127,500
-3,500 (-2.67%)
Nov 18, 2024, 3:30 PM KST
Daewoong Pharmaceutical Company Description
Daewoong Pharmaceutical Co., Ltd. manufactures and sells pharmaceutical products in South Korea and internationally.
It offers products in therapeutic areas, such as central nervous system, endocrinology, musculoskeletal, nephrology, antineoplastic, cardiovascular, gastrointestinal, metabolic, antiviral, analgesic, antacid, and digestive diseases, as well as wound, iron supplements, and muti-vitamins.
The company also provides COVID-19 PCR kit, COVID-19 IgG/IgM RDT, and viral transport medium medical devices.
The company was founded in 1945 and is headquartered in Seoul, South Korea.
Daewoong Pharmaceutical Co., Ltd
| Country | South Korea |
| Founded | 1945 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 1,710 |
Contact Details
Address: 12, Bongeunsa-ro 114-gil Seoul, 135-715 South Korea | |
| Phone | 82 2 550 8209 |
| Website | daewoong.com |
Stock Details
| Ticker Symbol | 069620 |
| Exchange | Korea Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | KRW |
| ISIN Number | KR7069620003 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Seongsoo Park | Chief Executive Officer and Executive Director |
| Chang-Jae Lee | Chief Executive Officer and Executive Director |
| Eunkyeong Park | Executive Director |